Apyx Medical rises on FDA clearance for loose skin treatment device

Apyx Medical

18/07/2022 16:25

** Apyx Medical Corp's shares  APYX.O  rise ~7% to $8.02
    ** APYX says it received clearance from the U.S. FDA for the
use of its device in procedures to improve the appearance of
loose skin on the neck and chin  urn:newsml:reuters.com:*:nBw5QFKYpa
    ** Co says it expects to start a limited launch of the
device, Renuvion, by the end of Q3; aims for full
commercialization by the end of 2022
    ** Stock is down 37% YTD

 (Reporting by Amruta Khandekar)
 ((Amruta.Khandekar@thomsonreuters.com;))